Sublingual Buprenorphine-Naloxone Exposure and Dental Disease

JAMA. 2023 Apr 11;329(14):1223-1224. doi: 10.1001/jama.2023.1501.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Buprenorphine, Naloxone Drug Combination* / administration & dosage
  • Buprenorphine, Naloxone Drug Combination* / therapeutic use
  • Humans
  • Narcotic Antagonists* / administration & dosage
  • Narcotic Antagonists* / therapeutic use
  • Stomatognathic Diseases* / chemically induced

Substances

  • Buprenorphine, Naloxone Drug Combination
  • Narcotic Antagonists